Financials
- Fiscal year
- 2025
- Total assets
- €503,586
- Profit
- €3,459
- Solvency
- 75.0%
Total assets▲ 33.6%
Net result
20192025
IH LIFE SCIENCES
ActiveSummary
IH LIFE SCIENCES has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €377,493 and a net result of €3,459. Equity is growing by ~4.3% per year across the filed fiscal years. Its solvency ranks better than 62% of 17112 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
What they do
Medical imaging and medical laboratories
NACE 86910NACE 86901
#10 company by equity in Zele, Health and social work sector1 site
How big
€503,586total assets 2025
- Equity
- €377,493
- Profit
- €3,459
Turnover not published (abridged schema)
Who decides
Accounts on time0 of 2 deeds read
Why 81+ Lower-failure-rate sector+ Annual accounts: healthy financial profileLatest accounts filed on timeShow the evidence
Checked score
Score 2025
Axes · tick = 2024
Profitability70▲+65
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30,000 at 30 days acceptable
Liquidity short (current ratio 0.45; short-term debt: 25% and cash: 7% of total assets), and 25% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
75%
Return on assets
0.7%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
on the day
2024
7 d late
2023
6 d early
2022
9 d early
2021
2 d early
2020
1 d early
2019
14 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 4 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today. Usually files around 28 April (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 close01-10-2026 today30-04-2027 deadline
- Annual accounts filedfiscal year 2025 · micro…
- Back to profitnet €3,459
- Annual accounts filedfiscal year 2024 · micro…
Key points
By topic
Timeline
- Events
- 12
- Since
- 2020
- Next accounts
- by 30-04-2027
- 30-04-2026Annual accounts filed
- 30-09-2025Back to profit
- 07-05-2025Annual accounts filed
Support & recognitions
- Recognitions
- 1 register
- LEI
- not active699400L3LFLITAP7VS45
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Medical imaging and medical laboratoriesNACE 86910
- Founded
- 12-01-2018
- Year ends
- 30-09
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.